<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">05607</article-id><article-id pub-id-type="doi">10.7554/eLife.05607</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genes and Chromosomes</subject></subj-group><subj-group subj-group-type="heading"><subject>Genomics and Evolutionary Biology</subject></subj-group></article-categories><title-group><article-title>The genetic architecture of NAFLD among inbred strains of mice</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-21662"><name><surname>Hui</surname><given-names>Simon T</given-names></name><aff><institution content-type="dept">Department of Medicine/Division of Cardiology, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country><email>sthui@mednet.ucla.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22100"><name><surname>Parks</surname><given-names>Brian W</given-names></name><aff><institution content-type="dept">Department of Medicine/Division of Cardiology, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22101"><name><surname>Org</surname><given-names>Elin</given-names></name><aff><institution content-type="dept">Department of Medicine/Division of Cardiology, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22104"><name><surname>Norheim</surname><given-names>Frode</given-names></name><aff><institution content-type="dept">Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine</institution>, <institution>University of Oslo</institution>, <addr-line><named-content content-type="city">Oslo</named-content></addr-line>, <country>Norway</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22105"><name><surname>Che</surname><given-names>Nam</given-names></name><aff><institution content-type="dept">Department of Medicine/Division of Cardiology, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22106"><name><surname>Pan</surname><given-names>Calvin</given-names></name><aff><institution content-type="dept">Department of Medicine/Division of Cardiology, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22102"><name><surname>Castellani</surname><given-names>Lawrence W</given-names></name><aff><institution content-type="dept">Department of Medicine/Division of Cardiology, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22103"><name><surname>Charugundla</surname><given-names>Sarada</given-names></name><aff><institution content-type="dept">Department of Medicine/Division of Cardiology, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22107"><name><surname>Dirks</surname><given-names>Darwin L</given-names></name><aff><institution content-type="dept">Department of Medicine/Division of Cardiology, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22108"><name><surname>Psychogios</surname><given-names>Nikolaos</given-names></name><aff><institution content-type="dept">Cardiovascular Research Center, Massachusetts General Hospital</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22110"><name><surname>Neuhaus</surname><given-names>Isaac</given-names></name><aff><institution content-type="dept">Department of Computational Genomics</institution>, <institution>Bristol-Myers Squibb</institution>, <addr-line><named-content content-type="city">Princeton</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22109"><name><surname>Gerszten</surname><given-names>Robert E</given-names></name><aff><institution content-type="dept">Cardiovascular Research Center, Massachusetts General Hospital</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22111"><name><surname>Kirchgessner</surname><given-names>Todd</given-names></name><aff><institution content-type="dept">Department of Cardiovascular Drug Discovery</institution>, <institution>Bristol-Myers Squibb</institution>, <addr-line><named-content content-type="city">Princeton</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22112"><name><surname>Gargalovic</surname><given-names>Peter S</given-names></name><aff><institution content-type="dept">Department of Computational Genomics</institution>, <institution>Bristol-Myers Squibb</institution>, <addr-line><named-content content-type="city">Princeton</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22114"><name><surname>Lusis</surname><given-names>Aldons J</given-names></name><aff><institution content-type="dept">Department of Medicine/Division of Cardiology, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-23497"><name><surname>Glass</surname><given-names>Christopher</given-names></name><role>Reviewing editor</role><aff><institution>University of California, San Diego</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>12</day><month>06</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e05607</elocation-id><supplementary-material><ext-link xlink:href="elife-05607-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>13</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>11</day><month>06</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Hui et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Hui et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>To identify genetic and environmental factors contributing to the pathogenesis of non-alcoholic fatty liver disease, we examined liver steatosis and related clinical and molecular traits in more than 100 unique inbred mouse strains which were fed a diet rich in fat and carbohydrates. A &amp;gt;30-fold variation in hepatic TG accumulation was observed among the strains. Genome wide association studies revealed three loci associated with hepatic TG accumulation. Utilizing transcriptomic data from the liver and adipose tissue, we identified several high-confidence candidate genes for hepatic steatosis, including <italic>Gde1</italic>, a glycerophosphodiester phosphodiesterase not previously implicated in triglyceride metabolism. We confirmed the role of <italic>Gde1</italic> by <italic>in vivo</italic> hepatic over-expression and shRNA knockdown studies. We hypothesize that <italic>Gde1</italic> expression increases TG production by contributing to the production of glycerol-3-phosphate. Our multi-level data, including transcript levels, metabolite levels, and gut microbiota composition, provide a framework for understanding genetic and environmental interactions underlying hepatic steatosis.</p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>metabolome</kwd><kwd>microbiome</kwd><kwd>genome-wide association</kwd><kwd>hepatic steatosis</kwd><kwd>transcriptome</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#92-169) of the University of California at Los Angeles.</p></fn></fn-group></back></article>